Literature DB >> 2196363

The use of oil-in-water emulsions as a vehicle for parenteral drug administration.

R J Prankerd1, V J Stella.   

Abstract

Oil-in-water emulsion formulations are useful for the parenteral administration of drugs which have significant delivery problems. Drugs may be incorporated into emulsion formulations either by emulsification of the drug dissolved in the oil phase, or by extemporaneous addition of a concentrated solution in a cosolvent to a commercial i.v. emulsion. Examples are given of the use of parental emulsion dosage forms for the delivery of drugs which have low water solubility, lack stability to hydrolysis, are irritant or have substantial affinity for plastic infusion sets. These examples are largely drawn from studies of novel cytotoxic agents. Emulsion dosage forms may also have some potential for site-directed drug delivery or for sustained release applications. The potential hazards of parenteral emulsions and some of the means of size determination of the dispersed oil droplets are also examined.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2196363

Source DB:  PubMed          Journal:  J Parenter Sci Technol        ISSN: 0279-7976


  11 in total

1.  Computed tomography-guided screening of surfactant effect on blood circulation time of emulsions: application to the design of an emulsion formulation for paclitaxel.

Authors:  Eun-Hye Lee; Soon-Seok Hong; So Hee Kim; Mi-Kyung Lee; Joon Seok Lim; Soo-Jeong Lim
Journal:  Pharm Res       Date:  2014-02-19       Impact factor: 4.200

2.  Influence of incorporation methods on partitioning behavior of lipophilic drugs into various phases of a parenteral lipid emulsion.

Authors:  Warisada Sila-on; Nontima Vardhanabhuti; Boonsri Ongpipattanakul; Poj Kulvanich
Journal:  AAPS PharmSciTech       Date:  2008-05-22       Impact factor: 3.246

3.  Complexities of particulate matter measurement in parenteral formulations of small-molecule amphiphilic drugs.

Authors:  Magali B Hickey; Sara Waggener; Dilip Gole; Ilias Jimidar; Hans Vermeersch; Poe Ratanabanangkoon; Arjen P Tinke; Örn Almarsson
Journal:  AAPS PharmSciTech       Date:  2011-01-14       Impact factor: 3.246

4.  A novel in vitro release method for submicron sized dispersed systems.

Authors:  N Chidambaram; D J Burgess
Journal:  AAPS PharmSci       Date:  1999

5.  Evidence for phospholipid bilayer formation in solid lipid nanoparticles formulated with phospholipid and triglyceride.

Authors:  H Heiati; N C Phillips; R Tawashi
Journal:  Pharm Res       Date:  1996-09       Impact factor: 4.200

6.  Pharmaceutical development of a parenteral formulation of the novel anti-tumor agent carzelesin (U-80,244).

Authors:  J D Jonkman-de Vries; M J de Graaff-Teulen; R E Henrar; J J Kettenes-van den Bosch; A Bult; J H Beijnen
Journal:  Invest New Drugs       Date:  1994       Impact factor: 3.850

7.  A method for the early evaluation of the effects of storage and additives on the stability of parenteral fat emulsions.

Authors:  J Li; K D Caldwell; B D Anderson
Journal:  Pharm Res       Date:  1993-04       Impact factor: 4.200

8.  4D-QSAR analysis of a set of propofol analogues: mapping binding sites for an anesthetic phenol on the GABA(A) receptor.

Authors:  Matthew D Krasowski; Xuan Hong; A J Hopfinger; Neil L Harrison
Journal:  J Med Chem       Date:  2002-07-18       Impact factor: 7.446

9.  Structures of nanoparticles prepared from oil-in-water emulsions.

Authors:  B Sjöström; A Kaplun; Y Talmon; B Cabane
Journal:  Pharm Res       Date:  1995-01       Impact factor: 4.200

10.  Preparation and evaluation of novel mixed micelles as nanocarriers for intravenous delivery of propofol.

Authors:  Xinru Li; Yanhui Zhang; Yating Fan; Yanxia Zhou; Xiaoning Wang; Chao Fan; Yan Liu; Qiang Zhang
Journal:  Nanoscale Res Lett       Date:  2011-03-31       Impact factor: 4.703

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.